Table 1.
Characteristics of included studies
| Author, year | Country | Study design | Sample size | Retention rate at follow-up | Women (%) | Age in years, mean (SD) | Cancer type(s) |
|---|---|---|---|---|---|---|---|
| Bantum, 2014 [61] | USA | RCT | 303 | 86.1% (303/352) | 82 | 49.3 (11) | Any type of cancer, completed treatment >4 weeks prior to study |
| Berg, 2014 [62] | USA | Pre-post | 19 | 79.2% (19/24) | 71 | 23.4 (3.9) | Adult (18–34 years) survivors of childhood cancers (any type) |
| Forbes, 2015 [63] | Canada | RCT | 87 | 91.6% (87/95) | 56 | 65.1 (8.5) | Breast, prostate and colorectal cancer survivors (96% currently disease free; 75% completed treatment) |
| Hatchett, 2013 [55] | USA | RCT | 74 | 87.1% (74/95) | 100 | No data | Breast cancer survivors, completed treatment |
| Hoffman, 2014 [64] | USA | Pre-post | 7 | 100% (7/7) | 71 | 64.6 (6.5) | NSCLC survivors (immediately before + after surgery/during treatment) |
| Hong, 2015 [65] | USA | Pre-post | 26 | 86.7% (26/30) | 69 | 69 (median) | Any type of cancer survivor, either undergoing or completed treatment |
| Kanera, 2016 [71] | Netherlands | RCT | 394a | 89.2% (462/518)a | 80 | 56.0 (11.4) | Any type of cancer, completed treatment >4 and <56 weeks prior to study, no recurrence |
| Kuijpers, 2016 [66] | Netherlands | Pre-post | 73 | 79.3% (73/92) | 100 | 49.5 (11.4) | Breast cancer survivors, either undergoing or completed treatment 3–12 months prior to study |
| Lee, 2014 [67] | South Korea | RCT | 57 | 96.6% (57/59) | 100 | 43.2 (5.1) | Breast cancer survivors, completed treatment <1 year prior to study |
| McCarroll, 2015 [68] | USA | Pre-post | 35 | 70.0% (35/50) | 100 | 58.4 (10.3) | Overweight/obese breast and/or endometrial cancer survivors with desire to lose weight, diagnosis <3 years prior to study |
| Puszkiewicz, 2016 [69] | UK | Pre-post | 11 | 100% (11/11) | 82 | 45 (9.4) | Breast, prostate or colorectal cancer survivors, completed treatment |
| Quintiliani, 2016 [70] | USA | Pre-post | 10 | 100% (10/10) | 100 | 58.6 (6.1) | Breast cancer survivors, >2 years since diagnosis and >6 months since end of treatment |
| Rabin, 2012 [54] | USA | RCT | 17 | 94.4% (17/18) | 56 | 32.2 (5.6) | Young adult (18–39) cancer survivors, completed treatment <10 years prior to study |
| Short, 2016 [72] | Australia | Pre-postb | 156b | 31.7%c (156/492) | 100 | 55.0 (9.7) | Breast cancer survivors, completed treatment |
| Valle, 2013 [53] | USA | RCT | 66 | 76.7% (36/86) | 91 | 31.7 (5.1) | Young adult (21–39) cancer survivors, diagnosed >18 years of age, >1 year since diagnosis, completed treatment |
aKanera et al. presented physical activity data for 394 participants (sample size used in meta-analysis); however, retention for other measures at follow-up was 462
bShort et al. (2016) is treated as a pre-post study due to the lack of control group across the three intervention arms
cShort et al.’s paper presents results for 3-month follow-up (immediately post-intervention) because retention rate at 6 months was very low (10.8% (53/492)). Sample size/retention rate presented here is for the 3-month follow-up